Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farid Farkouh

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Circulation. Arrhythmia and Electrophysiology|September 25, 2025
Mexiletine as Adjunctive Therapy in Atrial Fibrillation Following Dofetilide Treatment FailureCarlos Ceron, Raj Dalsania, Farid Farkouh, et al.
Cardiac Electrophysiology Clinics|January 29, 2026
Ionic and Cellular Basis of Antiarrhythmic Drug Therapy and Its Proarrhythmic RisksIbrahim Alameh, Farid Farkouh, Mohammed Kamareddine, et al.
JACC. Case Reports|May 21, 2026
When QTc Shrinks After Rhythm ConversionMohammed Hussein Kamareddine, Alyssa Zakala, Farid Farkouh, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Circulation. Arrhythmia and Electrophysiology|September 25, 2025
Mexiletine as Adjunctive Therapy in Atrial Fibrillation Following Dofetilide Treatment FailureCarlos Ceron, Raj Dalsania, Farid Farkouh, et al.
Cardiac Electrophysiology Clinics|January 29, 2026
Ionic and Cellular Basis of Antiarrhythmic Drug Therapy and Its Proarrhythmic RisksIbrahim Alameh, Farid Farkouh, Mohammed Kamareddine, et al.
JACC. Case Reports|May 21, 2026
When QTc Shrinks After Rhythm ConversionMohammed Hussein Kamareddine, Alyssa Zakala, Farid Farkouh, et al.
Pageof 1